CADL
Candel Therapeutics
$8.67
+$0.42 (+5.09%)Oct 28, 2026
Key metrics
The numbers that frame CADL today
- Market cap
- $663.42M
- ROIC
- -240.1%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $4.35
- 52wk High
- $14.00
Growth
Revenue and earnings trend for CADL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CADL
Is Candel Therapeutics a good buy?
Hold. Candel Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Candel Therapeutics is selling at a very high price.
What is the market capitalization of CADL?
Candel Therapeutics's market capitalization is $663.42M.
What is the 52-week high for CADL stock?
The 52-week high for Candel Therapeutics is $14.00. The current close of $8.67 is 38.1% below that high.
What is the 52-week low for CADL stock?
The 52-week low for Candel Therapeutics is $4.35. The current close of $8.67 is 99.3% above that low.
Does CADL stock pay dividends?
Candel Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CADL?
Candel Therapeutics's Debt / Equity ratio is 0.39.